2019-nCoV NAb Control (CLIA)
Manufactured by SHENZHEN YHLO BIOTECH Co. Ltd., China - http://www.szyhlo.com
Device identification number
1706
CE Marking
✓Yes
HSC common list (RAT)
×No
Format
Automated, Manual
Target type
Antibody
Commercial Status
Commercialised
Last Update
2022-08-24 09:08:01 CET
Assay Type
Immuno-Antibody
Reader Required
Yes
Subcategory
Calibrant / control sample
Method
Other ()
Time
30 minutes
Detection Principle
Chemiluminescence
LOD
0 AU
Calibration
Not evaluated
Analysis of cross reactivity
Not evaluated
Precision
Evaluated
Reproducibility
Evaluated
Robustness
Evaluated
The database contains publicly available In Vitro Diagnostic Medical Devices for COVID-19 and it is being updated periodically. Please note that additional performance (as retrieved from manufacturers web pages) is provided only for devices commercially available with CE-IVD mark. Acknowledgements